DLST and neuroblastoma: Moreover, loss of dihydrolipoamide S-succinyltransferase (DLST) that modulates entry of glutamine into the TCA cycle, impeded progression of MYCN-amplified neuroblastoma by impairing NADH production and OXPHOS activity [50].